Hyperhomocysteinemic mice show cognitive impairment without features of alzheimer's disease phenotype

Journal of Alzheimer's Disease

Volumn 35, Issue 1, 2013, Pages 59-66

  Rhodehouse, Bryce C ^a   Erickson, Michelle A ^b,c   Banks, William A ^b,c   Bearden, Shawn E ^a,d  

^a Nucl Eng Idaho State University   (United States)

^b VA PUGET SOUND HEALTH CARE SYSTEM   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d IDAHO STATE UNIVERSITY   (United States)

Author keywords

Alzheimer's disease; blood brain barrier; cognitive impairment; dementia; Homocysteine; microvascular permeability; microvessels

Indexed keywords

AMYLOID BETA PROTEIN[1-40]; AMYLOID BETA PROTEIN[1-42]; LRP1 PROTEIN; PGP PROTEIN; PROTEIN; RAGE PROTEIN; UNCLASSIFIED DRUG;

AGE; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN CORTEX; COGNITIVE DEFECT; CONTROLLED STUDY; DIENCEPHALON; FEMALE; HIPPOCAMPUS; HYPERHOMOCYSTEINEMIA; IMMUNODETECTION; IMMUNOPRECIPITATION; MALE; MAZE TEST; MESENCEPHALON; MICROVASCULATURE; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

EID: 84876360474     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-122347     Document Type: Article

References (33)

1. Sloane PD, Zimmerman S, Suchindran C, Reed P, Wang L, Boustani M, Sudha S (2002) The public health impact of Alzheimer's disease, 2000-2050: Potential implication of treatment advances. Annu Rev Public Health 23, 213-231. (Pubitemid 34508073)
2. Jaeger LB, Dohgu S, Hwang MC, Farr SA, Murphy MP, Fleegal-DeMotta MA, Lynch JL, Robinson SM, Niehoff ML, Johnson SN, Kumar VB, Banks WA (2009) Testing the neurovascular hypothesis of Alzheimer's disease: LRP-1 antisense reduces blood-brain barrier clearance, increases brain levels of amyloid-beta protein, and impairs cognition. J Alzheimers Dis 17, 553-570.
3. Deane R,Wu Z, Sagare A, Davis J, Du Yan S, Hamm K, Xu F, Parisi M, LaRue B, HuHW, Spijkers P, Guo H, Song X, Lenting PJ, Van Nostrand WE, Zlokovic BV (2004) LRP/amyloid beta-peptide interaction mediates differential brain efflux of Abeta isoforms. Neuron 43, 333-344. (Pubitemid 39061126)
4. Shibata M, Yamada S, Kumar SR, Calero M, Bading J, Frangione B, Holtzman DM, Miller CA, Strickland DK, Ghiso J, Zlokovic BV (2000) Clearance of Alzheimer's amyloid-ss (1-40) peptide from brain by LDL receptor-related protein-1 at the blood-brain barrier. J Clin Invest 106, 1489-1499. (Pubitemid 32038587)
5. Hartz AM, Miller DS, Bauer B (2010) Restoring blood-brain barrier P-glycoprotein reduces brain amyloid-beta in a mouse model of Alzheimer's disease. Mol Pharmacol 77, 715-723.
6. Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB, Jiang H, Prior JL, Sagare A, Bales KR, Paul SM, Zlokovic BV, Piwnica-Worms D, Holtzman DM (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115, 3285-3290. (Pubitemid 41567593)
7. Donahue JE, Flaherty SL, Johanson CE, Duncan JA, 3rd, Silverberg GD, Miller MC, Tavares R, Yang W, Wu Q, Sabo E, Hovanesian V, Stopa EG (2006) RAGE, LRP-1, and amyloidbeta protein in Alzheimer's disease. Acta Neuropathol 112, 405-415. (Pubitemid 44469161)
8. Deane R, Du Yan S, Submamaryan RK, LaRue B, Jovanovic S, Hogg E,Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9, 907-913. (Pubitemid 36889934)
9. Seshadri N, Messerli AW, Acharya N, Pearce GL, Jacobsen DW, Pohl MA, Robinson K, Sprecher DL (2004) Relation of homocysteine and C-reactive protein to urinary albumin loss. Am J Cardiol 93, 926-928. (Pubitemid 38429609)
10. Zhuo JM, Wang H, Pratico D (2011) Is hyperhomocysteinemia an Alzheimer's disease (AD) risk factor, an AD marker, or neither? Trends Pharmacol Sci 32, 562-571.
11. Zhang CE, Wei W, Liu YH, Peng JH, Tian Q, Liu GP, Zhang Y, Wang JZ (2009) Hyperhomocysteinemia increases betaamyloid by enhancing expression of gamma-secretase and phosphorylation of amyloid precursor protein in rat brain. Am J Pathol 174, 1481-1491.
12. Troen AM, Shea-Budgell M, Shukitt-Hale B, Smith DE, Selhub J, Rosenberg IH (2008) B-vitamin deficiency causes hyperhomocysteinemia and vascular cognitive impairment in mice. Proc Natl Acad Sci U S A 105, 12474-12479.
13. Streck EL, Bavaresco CS, Netto CA,WyseAT (2004) Chronic hyperhomocysteinemia provokes a memory deficit in rats in the Morris water maze task. Behav Brain Res 153, 377-381. (Pubitemid 38953111)
14. Beard RS Jr,Reynolds JJ, Bearden SE (2011) Hyperhomocysteinemia increases permeability of the blood-brain barrier by NMDA receptor-dependent regulation of adherens and tight junctions. Blood 118, 2007-2014.
15. Mayo JN, Beard RS Jr, Price TO, Chen CH, Erickson MA, Ercal N, Banks WA, Bearden SE (2012) Nitrative stress in cerebral endothelium is mediated by mGluR5 in hyperhomocysteinemia. J Cereb Blood Flow Metab 32, 825-834.
16. Owen JB, Sultana R, Aluise CD, Erickson MA, Price TO, Bu G, Banks WA, Butterfield DA (2010) Oxidative modification to LDL receptor-related protein 1 in hippocampus from subjects with Alzheimer disease: Implications for Abeta accumulation in AD brain. Free Radic Biol Med 49, 1798-1803.
17. Tucker KL, Qiao N, Scott T, Rosenberg I, Spiro A, 3rd (2005) High homocysteine and low B vitamins predict cognitive decline in aging men: The Veterans Affairs Normative Aging Study. Am J Clin Nutr 82, 627-635.
18. Quadri P, Fragiacomo C, Pezzati R, Zanda E, Forloni G, Tettamanti M, Lucca U (2004) Homocysteine, folate, and vitamin B-12 in mild cognitive impairment, Alzheimer disease, and vascular dementia. Am J Clin Nutr 80, 114-122. (Pubitemid 41115564)
19. Kalmijn S, Launer LJ, Lindemans J, Bots ML, Hofman A, Breteler MM (1999) Total homocysteine and cognitive decline in a community-based sample of elderly subjects: The Rotterdam Study. Am J Epidemiol 150, 283-289. (Pubitemid 29344955)
20. Riggs KM, Spiro A, 3rd, Tucker K, Rush D (1996) Relations of vitamin B-12, vitamin B-6, folate, and homocysteine to cognitive performance in the Normative Aging Study. Am J Clin Nutr 63, 306-314. (Pubitemid 26074688)
21. Silverberg GD, Miller MC, Messier AA, Majmudar S, Machan JT, Donahue JE, Stopa EG, Johanson CE (2010) Amyloid deposition and influx transporter expression at the blood-brain barrier increase in normal aging. J Neuropathol Exp Neurol 69, 98-108.
22. Liu LP, Hong H, Liao JM, Wang TS, Wu J, Chen SS, Li YQ, Long Y, Xia YZ (2009) Upregulation of RAGE at the bloodbrain barrier in streptozotocin-induced diabetic mice. Synapse 63, 636-642.
23. Banks WA, Kumar VB, Farr SA, Nakaoke R, Robinson SM, Morley JE (2011) Impairments in brain-to-blood transport of amyloid-beta and reabsorption of cerebrospinal fluid in an animal model of Alzheimer's disease are reversed by antisense directed against amyloid-beta protein precursor. J Alzheimers Dis 23, 599-605.
24. Gallucci M, Zanardo A, De Valentin L, Vianello A (2004) Homocysteine in Alzheimer disease and vascular dementia. Arch Gerontol Geriatr Suppl, 195-200. (Pubitemid 38822867)
25. Ehrlich D, Humpel C (2012) Chronic vascular risk factors (cholesterol, homocysteine, ethanol) impair spatial memory, decline cholinergic neurons and induce blood-brain barrier leakage in rats in vivo. J Neurol Sci.
26. Kamath AF, Chauhan AK, Kisucka J, Dole VS, Loscalzo J, Handy DE, Wagner DD (2006) Elevated levels of homocysteine compromise blood-brain barrier integrity in mice. Blood 107, 591-593. (Pubitemid 43090794)
27. Lominadze D, Roberts AM, Tyagi N, Moshal KS, Tyagi SC (2006)Homocysteine causes cerebrovascular leakage in mice. Am J Physiol Heart Circ Physiol 290, H1206-H1213.
28. Zhuo JM, Portugal GS, Kruger WD, Wang H, Gould TJ, Pratico D (2010) Diet-induced hyperhomocysteinemia increases amyloid-beta formation and deposition in a mouse model of Alzheimer's disease. Curr Alzheimer Res 7, 140-149.
29. Zhuo JM, Pratico D (2010) Normalization of hyperhomocysteinemia improves cognitive deficits and ameliorates brain amyloidosis of a transgenic mouse model of Alzheimer's disease. FASEB J 24, 3895-3902.
30. Zhuo JM, Pratico D (2010) Acceleration of brain amyloidosis in an Alzheimer's disease mouse model by a folate, vitamin B6 and B12-deficient diet. Exp Gerontol 45, 195-201.
31. Pacheco-Quinto J, Rodriguez de Turco EB, DeRosa S, Howard A, Cruz-Sanchez F, Sambamurti K, Refolo L, Petanceska S, Pappolla MA (2006) Hyperhomocysteinemic Alzheimer's mouse model of amyloidosis shows increased brain amyloid beta peptide levels. Neurobiol Dis 22, 651-656. (Pubitemid 43832135)
32. Zhuo JM, Pratico D (2010) Severe In vivo hyperhomocysteinemia is not associatedwith elevation of amyloidbeta peptides in the Tg2576 mice. J Alzheimers Dis 21, 133-140.
33. Pirchl M, Ullrich C, Humpel C (2010) Differential effects of short- and long-term hyperhomocysteinaemia on cholinergic neurons, spatial memory and microbleedings in vivo in rats. Eur J Neurosci 32, 1516-1527.